- Home
- ALZN vs HSCS Comparison
ALZN vs HSCS Comparison
Compare ALZN & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- HSCS
- Stock Information
- Founded
- ALZN 2016
- HSCS 2007
- Country
- ALZN United States
- HSCS United States
- Employees
- ALZN N/A
- HSCS N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- HSCS Medical Specialities
- Sector
- ALZN Health Care
- HSCS Health Care
- Exchange
- ALZN Nasdaq
- HSCS Nasdaq
- Market Cap
- ALZN 6.9M
- HSCS 3.1M
- IPO Year
- ALZN 2021
- HSCS 2022
- Fundamental
- Price
- ALZN $1.64
- HSCS $3.18
- Analyst Decision
- ALZN
- HSCS Strong Buy
- Analyst Count
- ALZN 0
- HSCS 1
- Target Price
- ALZN N/A
- HSCS $15.00
- AVG Volume (30 Days)
- ALZN 361.1K
- HSCS 1.0M
- Earning Date
- ALZN 12-13-2024
- HSCS 12-12-2024
- Dividend Yield
- ALZN N/A
- HSCS N/A
- EPS Growth
- ALZN N/A
- HSCS N/A
- EPS
- ALZN N/A
- HSCS N/A
- Revenue
- ALZN N/A
- HSCS $18,600.00
- Revenue This Year
- ALZN N/A
- HSCS $8,948.39
- Revenue Next Year
- ALZN N/A
- HSCS $27.27
- P/E Ratio
- ALZN N/A
- HSCS N/A
- Revenue Growth
- ALZN N/A
- HSCS 853.85
- 52 Week Low
- ALZN $1.40
- HSCS $2.36
- 52 Week High
- ALZN $33.00
- HSCS $52.00
- Technical
- Relative Strength Index (RSI)
- ALZN 40.84
- HSCS 40.32
- Support Level
- ALZN $1.58
- HSCS $3.38
- Resistance Level
- ALZN $1.90
- HSCS $5.30
- Average True Range (ATR)
- ALZN 0.14
- HSCS 0.35
- MACD
- ALZN 0.05
- HSCS -0.15
- Stochastic Oscillator
- ALZN 39.53
- HSCS 2.15
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About HSCS Heart Test Laboratories Inc.
Heart Test Laboratories Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.